Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

388 – Inflammatory and Microbial Signatures Linked to Cardiovascular Outcomes in People With/Without HIV

Background Chronic inflammation in people with HIV (PWH) is linked to cardiovascular disease (CVD). We previously described distinct inflammatory clusters from 24 biomarkers that were associated with CVD. We aimed to validate these results in an independent cohort and assess whether additional biomarkers or gut microbiome signatures could enhance CVD prediction in PWH. Methods In…

370 – Non-HIV Chronic/Latent Viruses and Immune Aging: Sex Effects Comparable to Those of HIV and CMV

Background Non-HIV chronic/latent Viruses (NHV) such as CMV, EBV, HHV-8, HSV-1, HSV-2, HCV, and HBV are associated with markers of aging and/or age-related diseases and play a role in the accelerated cellular aging in people living with HIV (PLWH). We investigated association(s) between sex, HIV status, and NHVs, and selected markers of immune aging, in…

337 – Vitamins K2 and D3 Improve Long COVID Index, Fungal Translocation, and Inflammatory Biomarkers

Background Long COVID (LC) is characterized by recurrent, prolonged, and new symptoms of COVID-19 at least 3 months after a SARS-COV-2 infection. LC was associated with fungal translocation, gut dysfunction, and enhanced inflammation. The anti-inflammatory vitamins K2/D3 were previously shown to reduce inflammation and help attenuate the course of acute COVID infection. This trial aims…

386 – Living With HIV Mimics the Proinflammatory FUT2 Non-Secretor Phenotype in the Intestines

Background The genetic FUT2 non-secretor status is phenotypically characterized by low levels of the glycan α1,2 fucose. Fucose in the intestines plays a crucial role in maintaining homeostasis between the gut and its microbiota, and loss of fucose can impair intestinal function and promote inflammation. While intestinal dysfunction and inflammation are well-documented in people with…

359 – Single-Cell Multi-Omics Uncovers the Immune Heterogeneity in HIV-Infected INRs

Background Immunological non-responders (INRs) are people living with HIV-1 who fail to achieve full immune reconstitution despite long-term effective antiretroviral therapy (ART). This incomplete recovery of CD4+ T cells increase the risk of opportunistic infections and non-AIDS-related morbidity and mortality. Understanding the mechanisms driving this immune dysfunction is critical for developing targeted therapies.  Methods We…

364 – Secreted ORF8 Reprograms Macrophages to Enhance Lung Epithelial Cell Infection by SARS-CoV-2

Background ORF8 is an accessory protein encoded by SARS-CoV-2, containing an immunoglobulin-like domain of approximately 20 kDa, and is secreted extracellularly by infected cells. Serum levels of ORF8 have been shown to correlate with disease severity in COVID-19 patients, though its exact function and target cells remain unknown. We hypothesized that extracellular ORF8 influences COVID-19…

378 – HIV Drives CARD8 Inflammasome Activation and Proinflammatory Cytokine Release by Myeloid Cells

Background Inflammasome activation in response to “danger-associated stimuli” including HIV can lead to the release of inflammatory cytokines such as IL-1ß and IL-18 as well as pyroptotic cell death. The HIV-1 protease can activate the CARD8 inflammasome in CD4 T cells, resulting in T-cell loss during untreated HIV infection. Since myeloid cells are equipped to…

356 – Relationship Between Gut Microbiome and Candida in PWH: Role of Bacterial Extracellular Vesicles

Background Candida is an opportunistic pathogen that can cause a variety of infections, from superficial to systemic, where the immune system is weakened. It has been suggested that the intestinal tract is a source of Candida infection; however, the role of commensal bacteria and intestinal immunity in Candida colonization in the intestinal tract is unclear.…

343 – CD40L/IL-4 Stimulated B Cells as Efficient Mediators of HIV-1 Binding and Trans Infection

Background Cell-to-cell HIV-1 transmission is a potent mechanism of HIV-1 pathogenesis. B and CD4+ T cells frequently interact in secondary lymphoid organs (SLO), thus potentially promoting B cell mediated HIV-1 trans infection. In SLO, B cells are stimulated through both stromal (BAFF) and CD4+ T cell (IL-4, IFN-g, CD40L) signals, however the impact of these…

333 – Bile Acids in the Modulation of Antiviral Immune Response

Background Bile acids (BAs) are produced from cholesterol in the liver as primary BAs and modified by gut microbiota becoming secondary BAs. Besides their primary role in solubilizing fats, these metabolites have been shown to modulate innate and adaptive immune function, making BAs a link between host metabolism and immune response. BAs regulation of immunity…